Results 291 to 300 of about 398,911 (393)

Managing Dystonia in Partington Syndrome

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Bilateral focal hand dystonia is an almost pathognomonic sign of Partington syndrome, frequently accompanied by intellectual disability and oromotor dyspraxia. However, a few studies have focused on the treatment of this focal dystonia, making patient management uncertain.
Emilie Pichon, Aurea Alioth, Sabina Catalano Chiuvé, André Zacharia, Marta Ruiz‐Lopez, David P. Breen, Florence Zangas‐Gehri, Florent Draye, Aurore Curie, Duncan Wilson, Victor S.C. Fung, Stephen Duma, Joël Fluss, Julien F. Bally   +13 more
wiley   +1 more source

System-level hypothesis of dopamine imbalance in early multiple sclerosis. [PDF]

Front Neurol
Caligiore D, Schirripa A, Biggio M.
europepmc   +1 more source

Prognostic Value of Parkinson's Disease Subtypes in the LABS‐PD Cohort: Functional Ability, Quality of Life and Mortality

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Research on Parkinson's disease (PD) heterogeneity may inform clinical prognosis. There is currently no fully validated PD subtype classification system. Objectives We aimed at assessing the prognostic relevance of a data‐driven PD subtype classification system.
Deepa Dash, Shirley Eberly, David Oakes, David Grimes, Anthony E. Lang, Caroline Tanner, Tiago A. Mestre, Connie Marras   +7 more
wiley   +1 more source

Optogenetic stimulation of midbrain dopaminergic neurons rescues hippocampal synaptic plasticity deficits in a mouse model of Alzheimer's disease. [PDF]

Transl Psychiatry
Ficchì S, Cauzzi E, La Barbera L, De Paolis ML, Loffredo G, Spoleti E, Ferrari I, Saba L, Biamonte F, Nobili A, Krashia P, D'Amelio M.   +11 more
europepmc   +1 more source

High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background DOPA decarboxylase (DDC) in cerebrospinal fluid (CSF) is an emerging Parkinson's disease (PD) biomarker, but its association with nonmotor symptoms is unclear. Objectives We aimed to determine if baseline DDC was associated with future cognitive decline in PD.
Andrea Sturchio, Wojciech Paslawski, Shervin Khosousi, Ioanna Markaki, Michael A. Nalls, Andrew B. Singleton, Hirotaka Iwaki, Per Svenningsson   +7 more
wiley   +1 more source

Strikingly different neurotransmitter release strategies in dopaminergic subclasses. [PDF]

Elife
Dorrego-Rivas A, Byrne DJ, Liu Y, Cheah M, Arslan C, Lipovsek M, Ford MC, Grubb MS.   +7 more
europepmc   +1 more source

Dopaminergic function in panic disorder

, 1991
William Pitchot, M. Ansseau, A. González Moreno, Michel Hansenne, R. von Frenckell   +4 more
openalex   +2 more sources

Comparative Analysis of the Incidence, Prevalence, and Survival of 8 Types of Parkinsonism in a Population‐Based Study with 367 Million Person Years of Observation over 21 Years

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Findings are contradictory regarding changes in the incidence and prevalence of Parkinson's disease (PD) over time; data for other parkinsonian disorders are rare. Objectives To analyze temporal trends in the incidence and prevalence of eight parkinsonisms (PD, MSA, PSP, CBS, DLB, vascular parkinsonism, drug‐induced parkinsonism ...
Sacha E. Gandhi, Katherine A. Grosset, Prasanth A. Iruthayaraj, Romel Gravesande, Lance Lee, Cathal Doyle, Yoav Ben‐Shlomo, Donald G. Grosset   +7 more
wiley   +1 more source

Effects of dopaminergic medication on upper limb motor function, strength and hand dexterity in people with Parkinson's disease. [PDF]

Clin Park Relat Disord
Alaei P, Wile DJ, Jakobi JM.
europepmc   +1 more source

Single-Cell Profiling Identifies Reward Behavior-Related Neurons and Alterations in the Ventral Tegmental Area Based on <i>Arvcf</i>-Knockout Mouse Model. [PDF]

Research (Wash D C)
Zhang M, Zhang B, Wang Y, Chang Q, He J, Yang Z, Li MD.   +6 more
europepmc   +1 more source